Our Essence Line of Urinary Hormones is Now Improved

As a leading laboratory in hormone testing, Genova Diagnostics is excited to announce a technology platform update to Complete Hormones™and our entire line of urinary hormone tests.

Highlights of this innovative update include:

  • Tandem Mass-Spectrometry (LC-MS/MS) now utilized to measure all parent estrogens and estrogen metabolites, providing a more comprehensive picture of estrogen metabolism
  • Diminished interference issues, translating into less non-reportable (NR) findings, for enhanced clinical utility and decreased inconvenience associated with re-testing
  • Updated Reference Ranges for estrogens and estrogen metabolites (including premenopausal women, postmenopausal women, and males)

Complete Hormones™ is Genova’s most comprehensive urinary hormone profile, and is designed to provide insight into the impact that shifting hormone levels may play in men (andropause or male menopause) and women (peri/menopause).

  • An easily-collected specimen, urine testing measures the most metabolites, providing a broader understanding of an individual's entire steroid-metabolism cascade.
  • Test results provide support for management of hormone-dependent symptoms and valuable insight into risk potential for hormone-associated cancers (breast, prostate) and osteoporosis.
  • Identification and targeted treatment of underlying hormonal imbalances with customized hormone therapy and/or nutritional interventions can improve symptoms and quality of life – and may reduce disease risk.

New platform launches December 1st, 2015!



Reference Ranges

As a result of the technology changes, Genova will also be providing updates to our estrogens and estrogen metabolite reference ranges.

  • Reference ranges have been derived from a questionnaire-qualified healthy population cohort and will be reported by menopause status and gender as follows:
    • Premenopause Female
    • Menopause Female
    • Male

In addition to the estrogen and estrogen metabolite reference range changes, the glucocorticoid (17-hydroxysteroid) Tetrahydrocortisone (THE) and A/C Balance reference ranges have also been updated on the Complete Hormones profile.

The estrogen and estrogen metabolite reference range changes will impact the following profiles: